Register entry
- Registered sites
- 3
- Active NDC listings
- 54
- Labeller names
- 3
- Live patents
- 61
- Exclusivities
- 1
- Countries
- 2
- Base
- United States
Authorisation
Registered operations
Finished drug manufacture2Relabelling1Repackaging2
Sites
Registered establishments
3| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Alcon Singapore Manufacturing Pte. Ltd.Registrant: Alcon Laboratories, Inc | 19 Tuas South Avenue 14, SG, 637313, Singapore (SGP) | Finished drug manufacture | 3010372291595170137 |
| Alcon Vision, LLCRegistrant: Alcon Laboratories, Inc | 6740 Business Parkway, Elkridge, Maryland (MD) 21075, United States (USA) | Repackaging | 3000215259835979527 |
| Alcon Research LLCRegistrant: Alcon Laboratories, Inc | 6201 South Freeway, Fort Worth, Texas (TX) 76134, United States (USA) | Finished drug manufacture, Relabelling, Repackaging | 1610287007672236 |
Catalogue
Drug listings by form and route
5454 active NDC listings: 30 human otc drug, 23 human prescription drug, 1 bulk ingredient. By marketing category: OTC MONOGRAPH DRUG 25, NDA 20, ANDA 8, BULK INGREDIENT 1.
| Dosage form | NDCs |
|---|---|
| solution/ drops | 23 |
| solution | 12 |
| emulsion | 7 |
| gel | 4 |
| kit | 2 |
| ointment | 2 |
| suspension/ drops | 2 |
| injection, solution | 1 |
| powder | 1 |
| Route | NDCs |
|---|---|
| ophthalmic | 51 |
| topical | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| alcon laboratories, inc. | 52 |
| alcon laboratories, inc. | 1 |
| alcon, inc. | 1 |
Exclusivity
Patents and exclusivities
61| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10174017 | RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylate | substance, product | Jan 2030 |
| 10654844 | RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylate | substance, product | Jan 2030 |
| 11028081 | RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylate | use | Jan 2030 |
| 11618748 | RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylate | use | Jan 2030 |
| 9421265 | SIMBRINZAbrimonidine tartrate; brinzolamide | product | Jun 2030 |
| 9044484 | SIMBRINZAbrimonidine tartrate; brinzolamide | product | Oct 2030 |
| 8394826 | RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylate | substance, product | Nov 2030 |
| 10028920 | TRYPTYRacoltremon | use | Sept 2031 |
| 9095609 | TRYPTYRacoltremon | product | Sept 2031 |
| 9433679 | TRYPTYRacoltremon | use | Sept 2031 |
| 8791154 | PATADAY ONCE DAILY RELIEFolopatadine hydrochloride | product | May 2032 |
| 9533053 | PATADAY ONCE DAILY RELIEFolopatadine hydrochloride | product | May 2032 |
| 10058511 | EYSUVIS, INVELTYSloteprednol etabonate | product | May 2033 |
| 10646436 | EYSUVISloteprednol etabonate | product | May 2033 |
| 10646437 | INVELTYSloteprednol etabonate | product | May 2033 |
| 10688045 | EYSUVIS, INVELTYSloteprednol etabonate | product | May 2033 |
| 10857096 | EYSUVISloteprednol etabonate | use | May 2033 |
| 10864219 | INVELTYSloteprednol etabonate | use | May 2033 |
| 10940108 | EYSUVISloteprednol etabonate | use | May 2033 |
| 10945948 | EYSUVISloteprednol etabonate | use | May 2033 |
| 10993908 | EYSUVISloteprednol etabonate | use | May 2033 |
| 11219596 | EYSUVISloteprednol etabonate | use | May 2033 |
| 11219597 | INVELTYSloteprednol etabonate | use | May 2033 |
| 11596599 | EYSUVISloteprednol etabonate | use | May 2033 |
| 11642317 | EYSUVIS, INVELTYSloteprednol etabonate | product | May 2033 |
| 11872318 | EYSUVIS, INVELTYSloteprednol etabonate | product | May 2033 |
| 12115246 | EYSUVIS, INVELTYSloteprednol etabonate | product | May 2033 |
| 9056057 | EYSUVIS, INVELTYSloteprednol etabonate | product | May 2033 |
| 9393213 | EYSUVIS, INVELTYSloteprednol etabonate | product | May 2033 |
| 9532955 | EYSUVIS, INVELTYSloteprednol etabonate | use | May 2033 |
| 9737491 | EYSUVIS, INVELTYSloteprednol etabonate | use | May 2033 |
| 9827191 | EYSUVIS, INVELTYSloteprednol etabonate | product | May 2033 |
| 10588901 | RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylate | substance, product | Mar 2034 |
| 11020385 | RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylate | use | Mar 2034 |
| 11185538 | RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylate | product | Mar 2034 |
| 11197853 | ROCKLATANlatanoprost; netarsudil dimesylate | product | Mar 2034 |
| 9415043 | RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylate | substance | Mar 2034 |
| 9931336 | RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylate | substance, product | Mar 2034 |
| 9993470 | ROCKLATANlatanoprost; netarsudil dimesylate | substance, product | Mar 2034 |
| 11850221 | TRYPTYRacoltremon | product | Dec 2042 |
| 12336971 | TRYPTYRacoltremon | use | Dec 2042 |
| Product | Exclusivity | Until |
|---|---|---|
| TRYPTYRACOLTREMON | NCE New chemical entity | May 2030 |
Catalogue
Marketed products
56Showing 54 of 56.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Alcaine | proparacaine hydrochloride | solution/ drops, ophthalmic | 0998-0016ANDA |
| Alcon Tears Lubricant Eye Drops | hypromellose 2910 | solution/ drops, ophthalmic | 0065-0408OTC MONOGRAPH DRUG |
| BION TEARS | Dextran, Hypromellose | solution/ drops, ophthalmic | 0065-0419OTC MONOGRAPH DRUG |
| BION TEARS | Dextran, Hypromellose | solution/ drops, ophthalmic | 0065-9305OTC MONOGRAPH DRUG |
| BSS | balanced salt solution | solution, ophthalmic | 0065-0795NDA |
| BSS | balanced salt solution | solution, ophthalmic | 0065-1795NDA |
| BSS PLUS | balanced salt solution enriched with bicarbonate, dextrose, and glutathione | kit | 0065-0800NDA |
| Betadine | povidone-iodine | solution, ophthalmic | 0065-0411NDA |
| Cyclogyl | cyclopentolate hydrochloride | solution/ drops, ophthalmic | 0065-0395ANDA |
| Cyclogyl | cyclopentolate hydrochloride | solution/ drops, ophthalmic | 0065-0396ANDA |
| Cyclogyl | cyclopentolate hydrochloride | solution/ drops, ophthalmic | 0065-0397ANDA |
| Cyclomydril | cyclopentolate hydrochloride and phenylephrine hydrochloride | solution/ drops, ophthalmic | 0065-0359ANDA |
| Eysuvis | loteprednol etabonate | suspension/ drops, ophthalmic | 71571-333NDA |
| FLUORESCITE | fluorescein sodium | injection, solution, ophthalmic | 0065-0092NDA |
| GenTeal Tears (Moderate) | Dextran 70, Glycerin, Hypromellose | solution/ drops, ophthalmic | 0065-0426OTC MONOGRAPH DRUG |
| GenTeal Tears Gel Drops | polyethylene glycol 400 and propylene glycol | gel, ophthalmic | 0065-8067OTC MONOGRAPH DRUG |
| GenTeal Tears Moderate Preservative Free | dextran 70, hypromellose 2910 | solution/ drops, ophthalmic | 0065-8063OTC MONOGRAPH DRUG |
| GenTeal Tears NIGHT-TIME | mineral oil, white petrolatum | ointment, ophthalmic | 0065-0518OTC MONOGRAPH DRUG |
| GenTeal Tears Severe | Hypromellose | gel, ophthalmic | 0065-8064OTC MONOGRAPH DRUG |
| Isopto Atropine | atropine sulfate | solution, ophthalmic | 0065-0303NDA |
| MIOSTAT | carbachol | solution, ophthalmic | 0065-0023NDA |
| Mydriacyl | tropicamide | solution/ drops, ophthalmic | 0065-0355ANDA |
| Mydriacyl | tropicamide | solution/ drops, ophthalmic | 0998-0355ANDA |
| - | NETARSUDIL MESYLATE | powder | 70727-324BULK INGREDIENT |
| Naphcon A | naphazoline hydrochloride and pheniramine maleate | solution/ drops, ophthalmic | 0065-0085NDA |
| PATADAY ONCE DAILY RELIEF | OLOPATADINE HYDROCHLORIDE | solution, ophthalmic | 0065-0816NDA |
| PATADAY ONCE DAILY RELIEF | OLOPATADINE HYDROCHLORIDE | solution, ophthalmic | 0065-8150NDA |
| PATADAY TWICE A DAY RELIEF | OLOPATADINE HYDROCHLORIDE | solution, ophthalmic | 0065-4274NDA |
| Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | solution/ drops, ophthalmic | 0065-0343NDA |
| Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | solution/ drops, ophthalmic | 0065-0349NDA |
| Rhopressa | netarsudil | solution/ drops, ophthalmic, topical | 70727-497NDA |
| Rocklatan | netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% | solution/ drops, ophthalmic, topical | 70727-529NDA |
| SIMBRINZA | brinzolamide/brimonidine tartrate | suspension/ drops, ophthalmic | 0065-4147NDA |
| SYSTANE HYDRATION PF PRESERVATIVE FREE | Polyethylene Glycol 400 and Propylene Glycol | solution/ drops, ophthalmic | 0065-1437OTC MONOGRAPH DRUG |
| SYSTANE HYDRATION PF PRESERVATIVE FREE | Polyethylene Glycol 400 and Propylene Glycol | solution/ drops, ophthalmic | 0065-1510OTC MONOGRAPH DRUG |
| Systane | polyethylene glycol 400 and propylene glycol | gel, ophthalmic | 0065-0454OTC MONOGRAPH DRUG |
| Systane | hypromellose | gel, ophthalmic | 0065-0474OTC MONOGRAPH DRUG |
| Systane Balance | propylene glycol | emulsion, ophthalmic | 0065-1433OTC MONOGRAPH DRUG |
| Systane COMPLETE | propylene glycol | emulsion, ophthalmic | 0065-0481OTC MONOGRAPH DRUG |
| Systane COMPLETE PF | propylene glycol | emulsion, ophthalmic | 0065-1509OTC MONOGRAPH DRUG |
| Systane COMPLETE PF | propylene glycol | emulsion, ophthalmic | 0065-1530OTC MONOGRAPH DRUG |
| Systane Complete PF | Propylene Glycol Emulsion | emulsion, ophthalmic | 0065-2509OTC MONOGRAPH DRUG |
| Systane Day and Night Value Pack | Polyethylene Glycol 400, Propylene Glycol 0.3% | kit | 0065-1502OTC MONOGRAPH DRUG |
| Systane Lubricant | polyethylene glycol 400 and Propylene Glycol | solution/ drops, ophthalmic | 0065-0429OTC MONOGRAPH DRUG |
| Systane Nighttime | mineral oil and white petrolatum | ointment, ophthalmic | 0065-0509OTC MONOGRAPH DRUG |
| Systane Pro PF | Propylene Glycol | emulsion, ophthalmic | 0065-3290OTC MONOGRAPH DRUG |
| Systane Pro PF | Propylene Glycol | emulsion, ophthalmic | 0065-9308OTC MONOGRAPH DRUG |
| Systane ULTRA | polyethylene glycol 400 and propylene glycol | solution/ drops, ophthalmic | 0065-1432OTC MONOGRAPH DRUG |
| Systane Ultra | Polyethylene Glycol 400 and Propylene Glycol | solution/ drops, ophthalmic | 0065-1431OTC MONOGRAPH DRUG |
| Systane Ultra Preservative Free | Polyethylene Glycol 400 and Propylene Glycol | solution/ drops, ophthalmic | 0065-1507OTC MONOGRAPH DRUG |
| TRYPTYR | Acoltremon | solution, ophthalmic, topical | 0065-8595NDA |
| Tetracaine Hydrochloride | tetracaine hydrochloride | solution, ophthalmic | 0065-0741NDA |
| Zaditor | ketotifen fumarate | solution, ophthalmic | 0065-4011ANDA |
| atropine sulfate | atropine sulfate | solution, ophthalmic | 0065-0817NDA |
Neighbours
Registered in the same town
8- Sotera Health LLCFort Worth, TX
- Pharma Packaging Solutions, LLC dba Tjoapack, LLCFort Worth, TX
- Prime Enterprises, LLC dba Prime Matter LabsFort Worth, TX
- MasVida Health Care Solutions, LLCFort Worth, TX
- Cook Children's Home HealthFort Worth, TX
- Eosera IncFort Worth, TX
- SOVEREIGN PHARMACEUTICALS, LLCFort Worth, TX
- Smith & Nephew, Inc.Fort Worth, TX
Compare
Comparable companies in United States
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Alk-Abello, Inc.3 sites · 412 NDC
- Conopco, Inc. d/b/a Unilever3 sites · 374 NDC
- L. Perrigo Company3 sites · 243 NDC
- Epic Laboratories, LLC3 sites · 209 NDC
- Safecor Health, LLC3 sites · 103 NDC
- ProPharma Distribution, LLC.3 sites · 100 NDC
- B. Braun US Pharmaceutical Manufacturing LLC3 sites · 94 NDC
- Aurolife Pharma LLC3 sites · 70 NDC
- Elementis Specialties (India) Private Limited3 sites · 69 NDC
Enquiry
Common questions
- Is Alcon Laboratories, Inc FDA approved?
- Alcon Laboratories, Inc holds 3 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Alcon Laboratories, Inc's drugs manufactured?
- At registered sites in Singapore, the United States. The FDA register lists SG; Elkridge, MD; Fort Worth, TX. Registered operations: finished drug manufacture, relabelling, repackaging.
- What drugs does Alcon Laboratories, Inc make?
- 56 products are listed under Alcon Laboratories, Inc in the openFDA NDC Directory, most often as solution/ drops; solution; emulsion. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.